Increased risk of infection reporting with anti‐BCMA bispecific monoclonal antibodies in multiple myeloma: A worldwide pharmacovigilance study

Saved in:
Bibliographic Details
Published in:American journal of hematology 2023-12, Vol.98 (12), p.E349-E353
Main Authors: Contejean, Adrien, Janssen, Cécile, Orsini‐Piocelle, Frédérique, Zecchini, Céline, Charlier, Caroline, Chouchana, Laurent
Format: Article
Language:English
Subjects:
Antibodies, Bispecific - adverse effects
Antibodies, Monoclonal - adverse effects
Bispecific antibodies
Hematology
Humans
Immunotherapy, Adoptive
Monoclonal antibodies
Multiple myeloma
Multiple Myeloma - drug therapy
Pharmacovigilance
T-Lymphocytes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0361-8609
1096-8652
1096-8652
DOI:10.1002/ajh.27071